about
Atypical IκB proteins - nuclear modulators of NF-κB signalingABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stabilityTNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activationSUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processingThe IkappaB kinase complex: master regulator of NF-kappaB signalingThe kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3Hepatitis B virus polymerase suppresses NF-κB signaling by inhibiting the activity of IKKs via interaction with Hsp90βIs NF-kappaB a good target for cancer therapy? Hopes and pitfallsThe Ubiquitination of NF-κB Subunits in the Control of TranscriptionRoles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic ApproachesCancer prevention with promising natural products: mechanisms of action and molecular targetsX-ray Structure of a NF-κB p50/RelB/DNA Complex Reveals Assembly of Multiple Dimers on Tandem κB SitesNF-kappaB: a multifaceted transcription factor regulated at several levelsGermline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiencyRescue of TRAF3-null mice by p100 NF-kappa B deficiencySubdomain VIII is a specificity-determining region in MEKK1NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activationTwo carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell linesOsteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alphaTWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κBc-IAP1 and c-IAP2 redundancy differs between T and B cells.TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbetaNon-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2.Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.Oncogenic activation of NF-kappaB.TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRsLoss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Structural Basis for the Activation of IKK1/αConstitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic miceInterferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsThe noncanonical NF-κB pathway.Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB.RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.A critical role for the NFkB pathway in multiple myeloma.
P2860
Q21245512-8F520691-1D44-4C16-BBBC-E6A327E17A26Q24294653-37130B96-F946-4179-9359-D49A42A542F9Q24297399-3F72E2A3-DA7F-455D-A014-2512EB546BA2Q24312155-F22AB18F-1041-4F4D-A325-E9EC74CC2CB1Q24313366-DC843715-6B80-47CB-BB6D-25AC2C083D2AQ24315115-EAE7C771-A7F9-4C12-BA79-512A4C3EE2A2Q24316194-B724092D-0974-4630-8DF9-FDBD5BA84EA4Q24338960-B01F9BC3-6773-45DF-8C9F-6369CFABCFBCQ24570128-0AB134C0-0096-4B57-A5D5-131149CBFE6EQ26748938-5B66F0D4-6B5B-4357-89B6-11D7C261BA71Q26752576-104268E8-1322-48F4-B786-C14A554BACCFQ27006530-682376D0-63D4-42F4-B0AD-7A856BDEA438Q27648171-F59DB354-6C6C-42F0-9B0E-2706D7DC1664Q28285466-FD0858A7-9F43-495E-80DD-F26305F2F518Q28300499-D106095A-5305-477C-ABFB-99496E46F128Q28506895-7E70242E-3B12-4DB4-ADE8-8256CF96DEBEQ28507577-CA49B31E-8AF7-4418-BBCF-E5B597B0C637Q28508229-5830B507-215A-496C-920F-9B68D296A65FQ28565703-03534385-833F-45FE-A571-10073E4455C0Q28593804-C1125AEF-1460-4630-AAB2-B8A8F1F3E1FCQ28749137-E966654E-CF5F-4CB0-847A-12779C98AAC9Q30361285-F70CE1CB-D6A9-422E-A1EC-6A7A51619F15Q31120747-A54A23EB-B6C4-47F9-B353-B4F573794F01Q31148506-01648DAC-52D8-4BC0-91C2-7A069D900D77Q33395224-D7382C4F-5FC0-42E8-BB04-E77FE3D51BAEQ33669288-F2605772-2AD8-4BAE-AB9E-E1DA174B74A6Q33737597-11E06F13-5D3F-4DE9-A40E-C5C65E880D03Q33839840-6664C094-2BFF-4254-8A87-9A90F21A5782Q33849388-20B36D1C-A872-4DF8-A182-678123DDD543Q33864629-B63AFEFA-AEAD-4E9F-A872-E222E744BDB8Q33882384-3FC747A8-9139-4996-8BF3-23DAAFE79F8FQ33889168-2363080F-D35F-49C6-BDEC-70C0368367B6Q33900720-B4A77CBB-DCF7-4F49-84DA-E02E129A06C0Q33943771-1226B376-66D6-4435-84BF-5BA5ADBD4C4AQ33997736-7986C071-023C-4571-A088-0A342FBB48D5Q34021737-04C3F52E-AF19-445E-AB7E-AB3380B39175Q34031207-E6A7BFC6-8762-4D26-951B-4EF6773FB270Q34101051-445B591D-8D0F-4486-B6FE-416F19E2FD1BQ34124144-89D3FACA-48FE-45F2-AE8D-9DBE109D44D2Q34165181-107023E7-53C0-4910-8A21-9D9FA9CDF6E0
P2860
description
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/10/15)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/10/15)
@nl
наукова стаття, опублікована в жовтні 2002
@uk
مقالة علمية (نشرت في 15-10-2002)
@ar
name
CD40 regulates the processing of NF-kappaB2 p100 to p52
@ast
CD40 regulates the processing of NF-kappaB2 p100 to p52
@en
CD40 regulates the processing of NF-kappaB2 p100 to p52
@nl
type
label
CD40 regulates the processing of NF-kappaB2 p100 to p52
@ast
CD40 regulates the processing of NF-kappaB2 p100 to p52
@en
CD40 regulates the processing of NF-kappaB2 p100 to p52
@nl
prefLabel
CD40 regulates the processing of NF-kappaB2 p100 to p52
@ast
CD40 regulates the processing of NF-kappaB2 p100 to p52
@en
CD40 regulates the processing of NF-kappaB2 p100 to p52
@nl
P2093
P2860
P3181
P356
P1433
P1476
CD40 regulates the processing of NF-kappaB2 p100 to p52
@en
P2093
G. G. B. Klaus
H. J. Coope
L. H. Johnston
M. J. Holman
P. G. P. Atkinson
P2860
P304
P3181
P356
10.1093/EMBOJ/CDF542
P407
P577
2002-10-15T00:00:00Z